Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.0005
Schlusskurs vom Vortag:
$0.0005
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.49M
KGV:
0.00
EPS:
-1.7861
Netto-Cashflow:
$-7.62M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-93.93%
1J Leistung:
-85.81%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$0.0007
Paxmedica Inc Stock (PXMD) Company Profile
Compare PXMD vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PXMD
Paxmedica Inc
|
0.00 | 0 | 0 | -13.49M | -7.62M | -1.7861 |
VRTX
Vertex Pharmaceuticals Inc
|
513.26 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
774.61 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.69 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.62 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
195.92 | 43.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Paxmedica Inc Aktie (PXMD) Neueste Nachrichten
PaxMedica Inc. (PXMD) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
PaxMedica Inc. (PXMD) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
PaxMedica Inc. (PXMD) Key Financial Ratios – Valuation, Profitability & More - Value Research
PaxMedica, Inc. Revenue Breakdown – OTC:PXMD - TradingView
PaxMedica, Inc. Revenue Breakdown – BMV:PXMD - TradingView
Enterprise value to revenue forward of PaxMedica, Inc. – OTC:PXMD - TradingView
Price to book forward of PaxMedica, Inc. – BMV:PXMD - TradingView
Price to earnings forward of PaxMedica, Inc. – OTC:PXMD - TradingView
Price to earnings forward of PaxMedica, Inc. – BMV:PXMD - TradingView
Number of shareholders of PaxMedica, Inc. – OTC:PXMD - TradingView
PaxMedica, Inc. Actuals & Estimates (OTC:PXMD) - TradingView
PaxMedica, Inc. Actuals & Estimates (BMV:PXMD) - TradingView
PaxMedica, Inc. has filed an IPO in the amount of $18.4575 million. - marketscreener.com
IOBTQ Stock Price and Chart — OTC:IOBTQ - TradingView
Strategic Execution in Focus for Paxmedica Investors - AD HOC NEWS
Comparing PaxMedica (NASDAQ:PXMD) & ProMetic Life Sciences (OTCMKTS:PFSCF) - Defense World
Paxmedica’s PAX-101 Under the Microscope: Pipeline Progress and FDA Milestones - AD HOC NEWS
CERO Stock Price and Chart — OTC:CERO - TradingView
CARM Stock Price and Chart — OTC:CARM - TradingView
Delisting of Securities from The Nasdaq Stock Market - Yahoo Finance
PaxMedica Renames to Kuvatris, Cancels Shares - TipRanks
QBIO Stock Price, News & Analysis - Stock Titan
PXMD Stock Price, News & Analysis - Stock Titan
CNBX Pharms Stock Price, News & Analysis - Stock Titan
VINC Stock Price and Chart — OTC:VINC - TradingView
PaxMedica announces board resignations amid transition - Investing.com
PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions - ACCESS Newswire
Craft Capital Management Announces Pricing of Initial Public Offering for PaxMedica, Inc. - ACCESS Newswire
PaxMedica Secures Groundbreaking China Patent for Autism Treatment Breakthrough After 100 Years - Stock Titan
CYTOF Stock Price and Chart — OTC:CYTOF - TradingView
PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection - Yahoo Finance
PaxMedica (NASDAQ: PXMD) Developing Treatments for Underserved Neurological Disorders - Barchart.com
PaxMedica (NASDAQ: PXMD) Shares Corporate Update, Commitment to Advancing Therapies for Neurological Disorders - Barchart.com
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101 - Yahoo Finance
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy - GlobeNewswire
PXMD Stock Price and Chart — OTC:PXMD - tradingview.com
Tardimed Sciences Llc Net WorthInsider Trades and Bio as of Apr 21, 2026 - Benzinga
PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast - GlobeNewswire
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Completes Key Step in Preparation of PAX-101 for NDA Submission to FDA - marketscreener.com
SRNE Stock Price and Chart — OTC:SRNE - TradingView
PaxMedica Receives Emergency Request for IV Suramin from - GlobeNewswire
Why Is PaxMedica (PXMD) Stock Up 93% Today? - TradingView
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission - Yahoo Finance
PaxMedica, Inc. (PXMD) stock price, news, quote and history - Yahoo Finance UK
PaxMedica, Inc. (PXMD) company profile and factsYahoo Finance - Yahoo Finance Singapore
PaxMedica prices stock and warrant offering at $1.30 per unit By Investing.com - Investing.com Canada
PaxMedica progresses with PAX-101 for sleeping sickness By Investing.com - Investing.com UK
PaxMedica's Chief Medical Officer Discusses FDA Meeting Highlights on The Bell2Bell Podcast - GlobeNewswire
Gapping stocks in Tuesday's session - ChartMill
PaxMedica Announces 1-for-17 Reverse Stock Split - Yahoo Finance
PaxMedica (NASDAQ: PXMD) Reports on Low-Dose Suramin for ASD Research - Digital Journal
Finanzdaten der Paxmedica Inc-Aktie (PXMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
4.36%
Kapitalisierung:
|
Volumen (24h):